ArticleBMC musculoskeletal disorders2024
Management and clinical-outcome of juxta-articular osteoid osteoma lesions.
Article in BMC musculoskeletal disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Scaphoid Osteoid Osteoma in a Pediatric Patient: A Case Report and Review of Diagnostic Pitfalls and Management Strategies.Case reports in orthopedics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionOsteoid osteoma (OO) is a benign intra-osseous lesion. The lesion is painful and usually diagnosed by x-ray, computed tomography (CT) or magnetic resonance imaging (MRI). When the lesion is juxta-articular or intra-capsular, the symptoms may present differently than the typical OO lesion and make diagnosis more challenging. Proximity to articular cartilage may make the treatment with radiofrequency ablation more dangerous. This study presents an 11-year experience in managing juxta-articular osteoid osteoma (JAOO) including long-term follow-up, while using CT-guided radiofrequency ablation (CT-RFA).
methodsAll patients diagnosed with OO and managed with CT-RFA between 2010 and 2020 were reviewed. Those with a lesion that was intra-capsular or less than 2 cm from the articular cartilage were included. Charts and all imaging studies were evaluated, and patients were interviewed by phone for any persistent or recurrent symptoms.
resultsThere were 168 patients with OO during this period and 59 met the criteria for inclusion. Forty-four (75%) were male and median age at the time of ablation was 20.7 years (range 3-59 years). Thirteen (22%) had active growth plates during ablation. Three patients (5%) required a repeat ablation for non-resolving pain. None of the 13 children with open physes had growth disturbance of the affected limb after ablation. In 3 patients, the typical OO pain resolved but an activity related pain persisted. One of them had articular damage that may be related to the CT-RFA.
conclusionJAOO may present challenges for diagnosis and treatment and CT-RFA is the current standard for treatment. Despite proximity to the cartilage and physis, careful attention to technique showed only one injury to these structures in this series of 59 patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.